Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
3.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 54(5): 272-0279, sept.-oct. 2019. tab, graf
Article in English | IBECS | ID: ibc-192714

ABSTRACT

Background: Anaemia is a very common condition in elderly patients with hip fracture. The side effects of blood transfusions are well known, and further research on potential alternative therapies is needed. Objectives and design: A non-controlled descriptive study, conducted on 138 patients admitted for hip fracture, aimed at analysing the effects of an anaemia treatment protocol adjunctive to transfusion, based on the use of supra-physiological doses of intravenous iron and erythropoietin (IS/EPOS). The variables collected were, medical history, physical and cognitive status prior to fracture, as well as the need of blood products, medical complications during admission and their functional outcome at three and six months after the fracture were evaluated. Transfusion rates were compared with a historical control group when the only treatment for acute anaemia was transfusion (2011). Results: Almost half (63, 48%) of the patients received blood transfusion, with (91,70%) IS/EPOD. Intravenous iron did not reduce the percentage of transfused patients (56% vs. 44%), but it did reduce the number of blood units required (0.7 units less in IS/EPO group). Patients who required transfusion had a longer hospital stay, (1.7 days; 13.2 vs. 11.5; p<0.005). Patients who received IS had better functional recovery assessed with Barthel index and the Functional Ambulation Categories (FAC scale) at 3 and 6 months after the fracture. Patients with malnutrition or subtrochanteric fracture needed more tabletransfusions (p<0.005). Functional recovery at 3 and 6 months after fracture was better in patients who received intravenous iron. Neither blood transfusions nor intravenous iron were associated with infectious complications or increased mortality. The patient series of this study was compared with a group of patients with hip fracture and similar characteristics seen in 2011, before intravenous iron was available, revealing a 17% reduction in blood transfusion needs (p<0.005). Conclusion: The use of intravenous iron in elderly patients with hip fracture may help to reduce the number of blood units needed for the treatment of anaemia, although a causal relationship cannot be established due to not having a control group. Transfusions were associated with longer hospital stay in elderly patients with hip fracture


Introducción: El síndrome anémico es muy frecuente en el anciano ingresado por fractura de cadera. Los documentados efectos secundarios de la transfusión de hemoderivados hacen necesario investigar otras posibles alternativas terapéuticas. Material y métodos: Estudio descriptivo de 138 pacientes ingresados por fractura de cadera que evalúa el efecto de un protocolo de tratamiento de anemia perioperatoria complementario a transfusión, basado en el empleo de dosis suprafisiológicas de hierro intravenoso y eritropoyetina (FE/EPO). Se trata de un estudio descriptivo sin grupo control. Se evaluaron los antecedentes médicos de los pacientes, y su situación mental y física previas al ingreso, la necesidad de hemoderivados, las complicaciones en el ingreso y su evolución funcional en los 6 meses posteriores a la fractura. Los ratios de transfusión fueron comparados con los de una muestra histórica de similares características sin tratamiento con ferroterapia intravenosa (2011). Resultados: Recibieron transfusión el 48% de los pacientes (63) y ferroterapia parenteral con eritropoyetina (FE/EPO) el 70% (91). La administración de FE/EPO no disminuyó el porcentaje de pacientes hemotransfundidos (56 vs. 44%) de forma significativa, pero sí redujo el número de unidades de sangre requeridas (0,7 unidades menos en grupo de FE/EPO). Los pacientes que recibieron ferroterapia intravenosa tuvieron una estancia hospitalaria de 1,7 días inferior que los transfundidos (11,5 vs. 13,2; p<0,005). La administración de hierro parenteral se relacionó con tendencia a una mejor recuperación de capacidad de autocuidados y deambulación medidos mediante el índice de Barthel (IB) y la escala de deambulación de Holden (FAC) a los 3 y 6 meses de la fractura. La anemia y la malnutrición al ingreso, así como el tipo de fracturas subtrocantérea se relacionaron de forma independiente a mayor necesidad de transfusión (p<0,005). Ni las transfusiones ni el tratamiento con ferroterapia parenteral se asociaron a más complicaciones infecciosas ni a mayor mortalidad. Al comparar la muestra actual con un control histórico de pacientes con fractura de cadera sin disponibilidad de tratamiento con hierro intravenoso, se observa reducción actual del porcentaje de pacientes transfundidos en un 17% (p<0,005). Conclusión: El empleo de ferroterapia intravenosa en pacientes con fractura de cadera puede reducir el número de unidades de hemoderivados necesarias, sí bien no se puede establecerse una relación causal al no ser un estudio controlado. La transfusión se asocia con una prolongación de la estancia hospitalaria en el anciano ingresado por fractura de cadera


Subject(s)
Humans , Male , Female , Aged, 80 and over , Anemia/etiology , Anemia/therapy , Blood Transfusion , Hip Fractures/complications , Clinical Protocols , Combined Modality Therapy , Treatment Outcome
4.
Rev Esp Geriatr Gerontol ; 54(5): 272-279, 2019.
Article in English | MEDLINE | ID: mdl-31266660

ABSTRACT

BACKGROUND: Anaemia is a very common condition in elderly patients with hip fracture. The side effects of blood transfusions are well known, and further research on potential alternative therapies is needed. OBJECTIVES AND DESIGN: A non-controlled descriptive study, conducted on 138 patients admitted for hip fracture, aimed at analysing the effects of an anaemia treatment protocol adjunctive to transfusion, based on the use of supra-physiological doses of intravenous iron and erythropoietin (IS/EPOS). The variables collected were, medical history, physical and cognitive status prior to fracture, as well as the need of blood products, medical complications during admission and their functional outcome at three and six months after the fracture were evaluated. Transfusion rates were compared with a historical control group when the only treatment for acute anaemia was transfusion (2011). RESULTS: Almost half (63, 48%) of the patients received blood transfusion, with (91,70%) IS/EPOD. Intravenous iron did not reduce the percentage of transfused patients (56% vs. 44%), but it did reduce the number of blood units required (0.7 units less in IS/EPO group). Patients who required transfusion had a longer hospital stay, (1.7 days; 13.2 vs. 11.5; p<0.005). Patients who received IS had better functional recovery assessed with Barthel index and the Functional Ambulation Categories (FAC scale) at 3 and 6 months after the fracture. Patients with malnutrition or subtrochanteric fracture needed more tabletransfusions (p<0.005). Functional recovery at 3 and 6 months after fracture was better in patients who received intravenous iron. Neither blood transfusions nor intravenous iron were associated with infectious complications or increased mortality. The patient series of this study was compared with a group of patients with hip fracture and similar characteristics seen in 2011, before intravenous iron was available, revealing a 17% reduction in blood transfusion needs (p<0.005). CONCLUSION: The use of intravenous iron in elderly patients with hip fracture may help to reduce the number of blood units needed for the treatment of anaemia, although a causal relationship cannot be established due to not having a control group. Transfusions were associated with longer hospital stay in elderly patients with hip fracture.


Subject(s)
Anemia/etiology , Anemia/therapy , Blood Transfusion , Hip Fractures/complications , Aged, 80 and over , Clinical Protocols , Combined Modality Therapy , Female , Humans , Male , Treatment Outcome
5.
Rev. esp. geriatr. gerontol. (Ed. impr.) ; 52(1): 27-30, ene.-feb. 2017. tab, graf
Article in Spanish | IBECS | ID: ibc-159273

ABSTRACT

Objetivo. Evaluar los resultados asistenciales y la repercusión económica de la intervención geriátrica en pacientes mayores de 75 años con fractura de cadera en fase aguda. Material y métodos. Estudio retrospectivo de los pacientes ingresados por fractura de cadera en el Hospital Universitario de Guadalajara (HUGU). Se evaluaron parámetros asistenciales del total de los pacientes ingresados por fractura de cadera en el HUGU entre los años 2002 y 2013 (n=2.942), tales como número anual de casos, la estancia preoperatoria, la estancia global y la mortalidad. Evaluación del efecto de la intervención geriátrica protocolizada iniciada en 2006 mediante la comparación de datos entre las etapas previa y posterior a su puesta en marcha. Resultados. La intervención geriátrica ha supuesto una reducción progresiva de estancia media y la mortalidad, aunque con una tendencia aumentar la estancia prequirúrgica. Comparando la actividad del 2013 con la del 2006, la estancia media se redujo del 18,5 al 11,2 días (-39,2%) y la mortalidad desde el 8,9 hasta el 6,8% (-23%). Por el contrario, la estancia preoperatoria media se mantuvo en 2,7 días de media en los años postintervención, frente a 2,4 en los años previos. A pesar del incremento anual del precio diario de la hospitalización por factura de cadera, el descenso de la estancia implica una reducción del coste del proceso que supera los 900.000 euros anuales. Conclusiones. La intervención geriátrica contribuye a la reducción observada de la mortalidad y la estancia hospitalaria por fractura de cadera, disminuyendo el coste de la hospitalización (AU)


Objective. To evaluate the healthcare outcomes and economic impact of geriatric intervention in patients over 75 years old with hip fracture in acute phase. Material and methods. Retrospective study of patients admitted to the University Hospital of Guadalajara (HUGU) due to hip fracture. An analysis was made of the number of cases per year, preoperative period, hospital stay, and mortality of all the patients over 75 years admitted to the HUGU due to hip fracture between 2002 and 2013. Results. A total of 2942 patients were included. Comparing the activity of 2013 to that of 2006, the mean hospital stay fell from 18.5 to 11.2 days (-39.2%), and mortality from 8.9% to 6.8% (-23%). In contrast, the mean preoperative stay remained at a mean of 2.7 days versus 2.4 in previous years in the early post-intervention period. Hospital stay decreased, despite a progressive annual increase in the daily cost of hospitalisation due to hip fracture surgery, the reduced stay led to a reduction of the total cost by more than 900,000 euros each year. Geriatric intervention has gradually reduced mean hospital stay and mortality, although with a tendency to increase mean preoperative stay. Conclusions. Geriatric intervention in patients with hip fracture reduces mortality and length of hospital stay, and decreasing costs (AU)


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Hip Fractures/economics , Hip Fractures/epidemiology , Hip Fractures/mortality , Hospitals, University/economics , Hospitals, University , Direct Service Costs/trends , Retrospective Studies , Hospitalization/economics , Length of Stay/economics , Length of Stay/statistics & numerical data
6.
Rev Esp Geriatr Gerontol ; 52(1): 27-30, 2017.
Article in Spanish | MEDLINE | ID: mdl-27034124

ABSTRACT

OBJECTIVE: To evaluate the healthcare outcomes and economic impact of geriatric intervention in patients over 75 years old with hip fracture in acute phase. MATERIAL AND METHODS: Retrospective study of patients admitted to the University Hospital of Guadalajara (HUGU) due to hip fracture. An analysis was made of the number of cases per year, preoperative period, hospital stay, and mortality of all the patients over 75 years admitted to the HUGU due to hip fracture between 2002 and 2013. RESULTS: A total of 2942 patients were included. Comparing the activity of 2013 to that of 2006, the mean hospital stay fell from 18.5 to 11.2 days (-39.2%), and mortality from 8.9% to 6.8% (-23%). In contrast, the mean preoperative stay remained at a mean of 2.7 days versus 2.4 in previous years in the early post-intervention period. Hospital stay decreased, despite a progressive annual increase in the daily cost of hospitalisation due to hip fracture surgery, the reduced stay led to a reduction of the total cost by more than 900,000 euros each year. Geriatric intervention has gradually reduced mean hospital stay and mortality, although with a tendency to increase mean preoperative stay. CONCLUSIONS: Geriatric intervention in patients with hip fracture reduces mortality and length of hospital stay, and decreasing costs.


Subject(s)
Hip Fractures/surgery , Aged , Aged, 80 and over , Female , Geriatrics , Hip Fractures/economics , Hip Fractures/epidemiology , Hospitalization , Humans , Male , Patient Admission , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...